Yahoo Web Search

Search results

    • FDA Approves Merck's Vaccine For Adult Invasive Pneumococcal Disease

      Morningstar· 7 hours ago

      By Emon Reiser The Food and Drug Administration approved Merck's Capvaxive, a vaccine to prevent the invasive bacterial infection pneumococcal disease in adults age 50 or older. Merck said that across four Phase 3 studies, Capvaxive "demonstrated